Moreover, the authors observed that using copeptin levels in addition to the National Institutes of Health Stroke Scale (NIHSS) score provided a better prediction for unfavorable outcomes than using the NIHSS score alone, showing the importance of such predictive biomarkers in everyday clinical practice [24]. This evidence concerns the gene AVP and stroke disorder.